Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis

By Heby O.   Persson L.   Rentala M.  

Amino Acids, Vol. 33, Iss. 2, 2007-08 ,pp. : 359-366

Springer Publishing Company

Access to resources Recommend Favorite

Trypanocidal and cytotoxic evaluation of synthesized thiosemicarbazones as potential drug leads against sleeping sickness

By Glinma Bienvenu   Kpoviessi Sika   Gbaguidi Fernand   Kapanda Coco   Bero Joanne   Quetin-Leclercq Joëlle   Moudachirou Mansourou   Poupaert Jacques   Accrombessi Georges   Gachomo Emma   Baba-Moussa Lamine   Kotchoni Simeon  

Molecular Biology Reports, Vol. 41, Iss. 3, 2014-03 ,pp. : 1617-1622

Springer Publishing Company

Access to resources Recommend Favorite

On the anticipation of the human dose in first-in-man trials from preclinical and prior clinical information in early drug development

By Lowe P. J.   Hijazi Y.   Luttringer O.   Yin H.   Sarangapani R.   Howard D.  

Xenobiotica, Vol. 37, Iss. 10-11, 2007-11 ,pp. : 1331-1354

Informa Healthcare

Access to resources Recommend Favorite

Pre-clinical pharmacokinetics of the acridine antitumour candidate AC04 and its 1-oxo-metabolite plasma profile

By Pigatto Maiara Cássia   Uchôa Flávia De Toni   Torres Bruna   Haas Sandra   do Carmo Alves de Lima Maria   Galdino Suely Lins   Rocha Pitta Ivan da   Peporine Lopes Norberto   Dalla Costa Teresa  

Xenobiotica, Vol. 42, Iss. 7, 2012-07 ,pp. : 701-707

Informa Healthcare

Access to resources Recommend Favorite

Role of AS04 in human papillomavirus vaccine: mode of action and clinical profile

By Garççon Nathalie   Wettendorff Martine   Van Mechelen Marcelle  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 5, 2011-05 ,pp. : 667-677

Informa Healthcare

Access to resources Recommend Favorite